- Home
- NEO vs EVV Comparison
NEO vs EVV Comparison
Compare NEO & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- EVV
- Stock Information
- Founded
- NEO 2001
- EVV 2003
- Country
- NEO United States
- EVV United States
- Employees
- NEO N/A
- EVV N/A
- Industry
- NEO Precision Instruments
- EVV Finance/Investors Services
- Sector
- NEO Health Care
- EVV Finance
- Exchange
- NEO Nasdaq
- EVV Nasdaq
- Market Cap
- NEO 1.2B
- EVV 1.2B
- IPO Year
- NEO 1999
- EVV N/A
- Fundamental
- Price
- NEO $10.60
- EVV $9.96
- Analyst Decision
- NEO Buy
- EVV
- Analyst Count
- NEO 10
- EVV 0
- Target Price
- NEO $12.56
- EVV N/A
- AVG Volume (30 Days)
- NEO 3.0M
- EVV 323.7K
- Earning Date
- NEO 10-28-2025
- EVV 01-01-0001
- Dividend Yield
- NEO N/A
- EVV 9.66%
- EPS Growth
- NEO N/A
- EVV N/A
- EPS
- NEO N/A
- EVV N/A
- Revenue
- NEO $709,162,000.00
- EVV N/A
- Revenue This Year
- NEO $10.74
- EVV N/A
- Revenue Next Year
- NEO $9.85
- EVV N/A
- P/E Ratio
- NEO N/A
- EVV N/A
- Revenue Growth
- NEO 10.10
- EVV N/A
- 52 Week Low
- NEO $4.72
- EVV $8.52
- 52 Week High
- NEO $19.12
- EVV $10.07
- Technical
- Relative Strength Index (RSI)
- NEO 59.78
- EVV 41.05
- Support Level
- NEO $9.89
- EVV $9.85
- Resistance Level
- NEO $10.44
- EVV $9.99
- Average True Range (ATR)
- NEO 0.52
- EVV 0.07
- MACD
- NEO -0.03
- EVV -0.01
- Stochastic Oscillator
- NEO 67.92
- EVV 36.48
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.